One of the most promising therapeutic targets for the repolarization of TAMs for cancer treatment is a blockade of the colony-stimulating factor (CSF)-1/colony-stimulating factor-1 receptor (CSF-1R) pathway. The gene discussed is CSF1R; the disease is cancer.